BAZ1B and lung carcinoma: In lung cancer, Meng et al. found that BAZ1B acts as an oncogene to promote tumor aggressiveness by inducing epithelial–mesenchymal transition (EMT) via activation of the PI3K/Akt and IL-6/STAT3 pathways [72].